======TARGET PRICE $6.35==== ENTRY LEVEL $5.00======.
CURE Pharmaceutical Holding Corp. focuses on the development and manufacturing of drug formulation and drug delivery technologies in novel dosage forms. Its commercial products include CURE 3068, and CURE 5079. The company was founded on May 15, 2014 and is headquartered in Oxnard, CA.
CURE Pharmaceutical Holding Corp. focuses on the development and manufacturing of drug formulation and drug delivery technologies in novel dosage forms. Its commercial products include CURE 3068, and CURE 5079. The company was founded on May 15, 2014 and is headquartered in Oxnard, CA.